Clinuvel Pharmaceuticals (CUV)

Stock Code


Stock Exchange


Clinuvel Pharmaceuticals (CUV) specialises in the manufacturing of biopharmaceuticals and prescription dermatology products. Clinuvel is engaged in the development of its innovative drug candidate afamelanotide. Afamelanotide (CUV1647) is a preventative photoprotective drug intended for use in a range of skin disorders caused by ultra violet (UV) radiations; and cancer related treatments. CUV1647 protects skin from UV radiation (UVR) by stimulating the body’s natural ability to produce eumelanin, the dark pigment of the skin having photoprotective properties.

Clinuvel Pharmaceuticals Dividends

18 October, 2010 - 01:08

Study the old dividends for Clinuvel Pharmaceuticals. Dividends are payments made by a corporation to its shareholder members. It is the portion of corporate profits paid out to stockholders. If Clinuvel Pharmaceuticals Limited has declared a dividend, you may be eligible to receive CUV dividends if the share trader the company's stock on the ex-dividend date. Investors must have purchase the shares before the ex dividend date to be entitled to the dividend declared by the company.

Syndicate content

Recommended Websites